Product Details
High-order Aspheric Foldable Intraocular Lens
Product Parameters
Product | High-order Aspherical Hydrophilic Acrylic Intraocular Lens |
Manufacturer | Henan Universe IOL R&M Co., Ltd |
Model | PCF60/AL |
Overall Length (mm) | 12.75 |
Optic diameter (mm) | 6.0 |
Material | Hydrophilic Acrylic |
Optical design | Monofocal, aspheric |
Haptic anglulation | 5° |
Haptic Type | Modified “C” Loop |
Edge Type | 360° square edge |
Product Features
- High-order aspheric: accommodate eccentric or inclined image
quality problems after intraocular lens implantation to the
greatest extent, and has a higher MTF value to ensure excellent
postoperative visual quality.
- Zero spherical aberration: provides patients with improved contrast
sensitivity in mesopic, photopic and dim light conditions.
- 360° square edge: maximize the blocking of LEC cells from migrating
to the posterior capsule and minimize the incidence of PCO.
- Medified C haptics: provides excellent stability for the
intraocular lens in the capsular bag.
Company Profile
Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
was founded in 1991, is one of the first enterprises in China to
produce intraocular lenses and related products. It has introduced
advanced American technology and established a complete automated
production line, integrating R&D, production, and sales. After
30 years of development, it has become China A benchmark enterprise
in the field of intraocular lenses.
Till now, our company has products in sale, such as PMMA
Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma
Drainage Implants, Hydroxypropyl Methylcellulose, Sodium
Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector
for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in
1991, with very low incidences of adverse effects and serious
adverse events.
The highest eminence is to be gianed step by step. Henan Universe
Intraocular Lens Research and Manufacture Co., Ltd. will work hard
and innovate constantly to improve the quantity of products,
elevate the core competitiveness of the enterprise and make even
greater contribution to the human health undertaking.